Newspaper Publication for Audited Financial Results of the Company for the quarter and year ended March 31, 2026
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anthem Biosciences Ltd has notified exchanges about the newspaper publication of its audited consolidated and standalone financial results for Q4 and FY ended March 31, 2026. The results were published on May 5, 2026 in Financial Express (English) and Vishwavani (Kannada). The filing confirms compliance with SEBI Listing Regulations (Regulation 47). The company appears to have reported growth metrics including approximately 24% year-on-year growth and mentioned figures around Rs 84 crore for the quarter, with QoQ comparisons indicating positive momentum. This is a routine regulatory compliance filing for a newly listed company (BSE: 544449, NSE: ANTHEM).
This filing confirms that Anthem Biosciences has completed its FY2026 audit and disclosed results publicly as required by listing regulations. For shareholders, this indicates the company remains compliant with regulatory requirements and has formally published its annual performance data. The actual impact on stock price will depend on the underlying financial metrics detailed in the newspaper advertisements.